Eignapharma
Eignapharma, a leading name in the pharmaceutical industry, is headquartered in Spain (ES) and operates extensively across Europe and beyond. Founded in 2010, the company has established itself as a key player in the development and distribution of innovative healthcare solutions, focusing on both prescription and over-the-counter products. Eignapharma's core offerings include a diverse range of pharmaceuticals, with a particular emphasis on specialty medications that address unmet medical needs. Their commitment to quality and research-driven development sets them apart in a competitive market. With a strong market position, Eignapharma has achieved significant milestones, including strategic partnerships and a growing portfolio of patented formulations. The company continues to enhance its reputation for excellence in the pharmaceutical sector, driven by a dedication to improving patient outcomes.
DitchCarbon Score
How does Eignapharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eignapharma's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eignapharma's reported carbon emissions
Eignapharma, headquartered in Spain (ES), currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that Eignapharma has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi). Additionally, there are no climate pledges documented, which suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, Eignapharma's future climate commitments and initiatives will be crucial in aligning with industry standards and addressing global climate challenges.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eignapharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
